Anti-inflammatory drugs for pain during medical abortion
Part of Brain & nervous system, Women’s health & pregnancy clinical trials.
This study tests whether giving anti-inflammatory drugs before or during a medical abortion (13–22 weeks) can help prevent pain better than treating pain once it starts. If you're eligible, taking part may help improve pain management for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and pregnant.
- Your pregnancy is between 13 and 22 weeks (about 3 to 5 months).
- The pregnancy cannot continue (due to stillbirth, a serious fetal condition, or your choice after counseling).
- You are willing to take part and can sign a consent form.
- You do not have serious health problems like bleeding disorders, heart conditions, or uncontrolled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining two medications (lidocaine and ketorolac) given as a shot around the cervix can help with pain when placing small sticks (dilators) to prepare for an abortion procedure. If you are 16–24 weeks pregnant and planning an abortion, this trial may help you feel less discomfort.
This study tests whether a pain prediction tool can help choose the best pain medicine before an in-office gynecologic procedure like IUD insertion or biopsy. If you join, you may get more personalized pain relief.
This study tests whether taking letrozole or mifepristone before medication helps the medical abortion work better for pregnancies up to 10 weeks. You may be asked to try another method (repeat medicine or a procedure) if the first treatment does not fully work.
This study tests whether adding diphenhydramine (a common allergy medicine) to sedation helps patients feel more comfortable during a procedural abortion in the first trimester. Researchers want to see if it improves pain control and overall experience.
This trial tests two different medicines (Mifepristone vs Misoprostol) to see which works better for ending a pregnancy in the second trimester (12–16 weeks). It is for people who are pregnant with one baby and have no major health issues that could affect safety.
This study tests if taking only misoprostol (instead of the usual two-pill regimen) is safe and effective for ending early pregnancy. It may offer a simpler option for people up to 11 weeks pregnant.
Hear when a new Pain Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.